CASSIDY BANKS: Open Payments
NPI 1982309357 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,727 in 69 payments from 26 companies in 2025. Trend: 2023 $449 · 2024 $979 · 2025 $1,727
Food & beverage: $1,727
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 9 | $216 |
| Ferring Pharmaceuticals Inc. | 8 | $163 |
| Sumitomo Pharma America, Inc. | 6 | $147 |
| Dendreon Pharmaceuticals LLC | 6 | $137 |
| AngioDynamics, Inc. | 1 | $126 |
| Janssen Biotech, Inc. | 3 | $104 |
| UROGEN PHARMA, INC. | 3 | $92 |
| Tempus AI, Inc | 3 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $82 |
| Antares Pharma, Inc. | 4 | $72 |
Products named: ADSTILADRIN, PROVENGE, NANOKNIFE, ORGOVYX, ERLEADA, General - Erectile Dysfunction, AMS 700, XT CDX.
Industry payments across GA — which companies pay providers there.
